Risperidone treatment of tardive dyskinesia and dystonia.
Chong
S A
SA
Remington
G
G
Tan
C H
CH
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D004421:Dystonia / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D014282:Trihexyphenidyl / Q000627:therapeutic use
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D012702:Serotonin Antagonists; D014282:Trihexyphenidyl; D018967:Risperidone; D003975:Diazepam